Holdings of Select Pharmaceuticals Portfolio
Fidelity Select Portfolios · Original filing · Compare with another fund · Report an error
- Net assets
- 1.5B $ including 1.5B $ in equities, 99.1 %
- Positions
- 46 in 11 countries
- Top ten
- 74.6 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 362,801 | 381.7M $ | 25.18 % |
| 2 | GSK PLC | 2,581,360 | 152.6M $ | 10.07 % |
| 3 | Johnson & Johnson | 459,700 | 114.2M $ | 7.53 % |
| 4 | UCB SA | 254,500 | 75.9M $ | 5.01 % |
| 5 | Roche Holding AG | 157,090 | 74.8M $ | 4.93 % |
| 6 | AstraZeneca PLC | 358,250 | 74.7M $ | 4.93 % |
| 7 | Gilead Sciences Inc | 472,500 | 70.4M $ | 4.64 % |
| 8 | Merck & Co Inc | 561,536 | 69.5M $ | 4.59 % |
| 9 | Elanco Animal Health Inc | 2,536,200 | 67M $ | 4.42 % |
| 10 | LEGEND BIOTECH CORP | 2,598,400 | 49.4M $ | 3.26 % |
| 11 | Jazz Pharmaceuticals PLC | 227,700 | 43.3M $ | 2.85 % |
| 12 | Moderna Inc | 688,800 | 36.9M $ | 2.43 % |
| 13 | Royalty Pharma PLC | 750,500 | 34.7M $ | 2.29 % |
| 14 | Viatris Inc | 1,729,600 | 25.8M $ | 1.70 % |
| 15 | Financiere de Tubize SA | 91,587 | 24.5M $ | 1.62 % |
| 16 | BioNTech SE | 132,653 | 14.6M $ | 0.96 % |
| 17 | Merck KGaA | 94,700 | 14.3M $ | 0.95 % |
| 18 | Biogen Inc | 73,000 | 14M $ | 0.92 % |
| 19 | Ocular Therapeutix Inc | 1,331,717 | 11.9M $ | 0.79 % |
| 20 | Beam Therapeutics Inc | 415,400 | 11.8M $ | 0.78 % |
| 21 | Xenon Pharmaceuticals Inc | 268,600 | 11.6M $ | 0.77 % |
| 22 | uniQure NV | 705,578 | 11M $ | 0.73 % |
| 23 | Capricor Therapeutics Inc | 389,900 | 10.9M $ | 0.72 % |
| 24 | PTC Therapeutics Inc | 155,600 | 10.6M $ | 0.70 % |
| 25 | Kymera Therapeutics Inc | 102,000 | 9.3M $ | 0.61 % |
| 26 | Phibro Animal Health Corp | 150,755 | 8.2M $ | 0.54 % |
| 27 | Axsome Therapeutics Inc | 48,900 | 8M $ | 0.53 % |
| 28 | Annexon Inc | 1,264,100 | 7.1M $ | 0.47 % |
| 29 | Ascendis Pharma A/S | 24,400 | 5.7M $ | 0.38 % |
| 30 | Corcept Therapeutics Inc | 158,100 | 5.6M $ | 0.37 % |
| 31 | Intellia Therapeutics Inc | 384,500 | 5.3M $ | 0.35 % |
| 32 | Crinetics Pharmaceuticals Inc | 122,800 | 5M $ | 0.33 % |
| 33 | Harmony Biosciences Holdings Inc | 158,577 | 4.5M $ | 0.30 % |
| 34 | Arrowhead Pharmaceuticals Inc | 65,400 | 4.1M $ | 0.27 % |
| 35 | WaVe Life Sciences Ltd | 296,800 | 4.1M $ | 0.27 % |
| 36 | Vera Therapeutics Inc | 100,700 | 4.1M $ | 0.27 % |
| 37 | Amylyx Pharmaceuticals Inc | 257,800 | 3.9M $ | 0.26 % |
| 38 | Disc Medicine Inc | 53,800 | 3.6M $ | 0.24 % |
| 39 | Definium Therapeutics Inc | 188,000 | 3.3M $ | 0.22 % |
| 40 | Idorsia Ltd | 639,660 | 3.3M $ | 0.21 % |
| 41 | Summit Therapeutics Inc | 169,304 | 2.8M $ | 0.19 % |
| 42 | Edgewise Therapeutics Inc | 83,600 | 2.5M $ | 0.17 % |
| 43 | ArriVent Biopharma Inc | 107,000 | 2.5M $ | 0.16 % |
| 44 | Viking Therapeutics Inc | 64,300 | 2.2M $ | 0.14 % |
| 45 | AGOMAB THERAPEUTICS SA | 9,100 | 145.8K $ | 0.01 % |
| 46 | Ionis Pharmaceuticals Inc | 100 | 8.1K $ | 0.00 % |
Sector breakdown
- Health care 77.1 %
- Unattributed 22.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 87.2 %
- EUR 7.6 %
- CHF 5.2 %
The quoted currency of each line, as declared.
Country breakdown
- United States 62.5 %
- United Kingdom 15.1 %
- Belgium 6.7 %
- Switzerland 5.2 %
- Cayman Islands 3.3 %
- Ireland 2.9 %
- Germany 1.9 %
- Canada 1.0 %
- Netherlands 0.7 %
- Denmark 0.4 %
- Singapore 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 30 | 938.3M $ | 62.49 % |
| 2 | United Kingdom | 2 | 227.3M $ | 15.14 % |
| 3 | Belgium | 3 | 100.5M $ | 6.70 % |
| 4 | Switzerland | 2 | 78M $ | 5.20 % |
| 5 | Cayman Islands | 1 | 49.4M $ | 3.29 % |
| 6 | Ireland | 1 | 43.3M $ | 2.88 % |
| 7 | Germany | 2 | 29M $ | 1.93 % |
| 8 | Canada | 2 | 14.9M $ | 0.99 % |
| 9 | Netherlands | 1 | 11M $ | 0.73 % |
| 10 | Denmark | 1 | 5.7M $ | 0.38 % |
| 11 | Singapore | 1 | 4.1M $ | 0.28 % |
Cite this page
Titelia. "Holdings of Select Pharmaceuticals Portfolio". https://titelia.com/en/funds/S000007481